Clinical Trial Update: Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing melphalan, prednisone, and thalidomide versus melphalan and prednisone in elderly multiple myeloma patients; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)

Snippet

Sponsor: Gruppo Italiano per lo Studio del Mieloma Multiplo | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED